These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20940007)

  • 1. Pre-conditioning cryosurgery: cellular and molecular mechanisms and dynamics of TNF-α enhanced cryotherapy in an in vivo prostate cancer model system.
    Jiang J; Goel R; Schmechel S; Vercellotti G; Forster C; Bischof J
    Cryobiology; 2010 Dec; 61(3):280-8. PubMed ID: 20940007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancer.
    Chao BH; He X; Bischof JC
    Cryobiology; 2004 Aug; 49(1):10-27. PubMed ID: 15265713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha-based accentuation in cryoinjury--dose, delivery, and response.
    Goel R; Swanlund D; Coad J; Paciotti GF; Bischof JC
    Mol Cancer Ther; 2007 Jul; 6(7):2039-47. PubMed ID: 17620433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha-induced accentuation in cryoinjury: mechanisms in vitro and in vivo.
    Jiang J; Goel R; Iftekhar MA; Visaria R; Belcher JD; Vercellotti GM; Bischof JC
    Mol Cancer Ther; 2008 Aug; 7(8):2547-55. PubMed ID: 18723499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of timing, dose and interstitial versus nanoparticle delivery of tumor necrosis factor alpha in combinatorial adjuvant cryosurgery treatment of ELT-3 uterine fibroid tumor.
    Jiang J; Bischof J
    Cryo Letters; 2010; 31(1):50-62. PubMed ID: 20309509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryosurgery of normal and tumor tissue in the dorsal skin flap chamber: Part II--injury response.
    Hoffmann NE; Bischof JC
    J Biomech Eng; 2001 Aug; 123(4):310-6. PubMed ID: 11563755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant approaches to enhance cryosurgery.
    Goel R; Anderson K; Slaton J; Schmidlin F; Vercellotti G; Belcher J; Bischof JC
    J Biomech Eng; 2009 Jul; 131(7):074003. PubMed ID: 19640135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoinjury of MCF-7 human breast cancer cells and inhibition of post-thaw recovery using TNF-alpha.
    Han B; Swanlund DJ; Bischof JC
    Technol Cancer Res Treat; 2007 Dec; 6(6):625-34. PubMed ID: 17994793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryosurgery of normal and tumor tissue in the dorsal skin flap chamber: Part I--thermal response.
    Hoffmann NE; Bischof JC
    J Biomech Eng; 2001 Aug; 123(4):301-9. PubMed ID: 11563754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryosurgery of dunning AT-1 rat prostate tumor: thermal, biophysical, and viability response at the cellular and tissue level.
    Bischof JC; Smith D; Pazhayannur PV; Manivel C; Hulbert J; Roberts KP
    Cryobiology; 1997 Feb; 34(1):42-69. PubMed ID: 9028916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1-weighted MR image contrast around a cryoablation iceball: a phantom study and initial comparison with in vivo findings.
    Overduin CG; Bomers JG; Jenniskens SF; Hoes MF; Ten Haken B; de Lange F; Fütterer JJ; Scheenen TW
    Med Phys; 2014 Nov; 41(11):112301. PubMed ID: 25370657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy.
    Shenoi MM; Iltis I; Choi J; Koonce NA; Metzger GJ; Griffin RJ; Bischof JC
    Mol Pharm; 2013 May; 10(5):1683-94. PubMed ID: 23544801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryotherapy of prostate cancer.
    Loening S; Hawtrey C; Bonney W; Narayana A; Culp DA
    Prostate; 1980; 1(3):279-86. PubMed ID: 7279801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vivo study of antifreeze protein adjuvant cryosurgery.
    Pham L; Dahiya R; Rubinsky B
    Cryobiology; 1999 Mar; 38(2):169-75. PubMed ID: 10191041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis.
    Kimura K; Bowen C; Spiegel S; Gelmann EP
    Cancer Res; 1999 Apr; 59(7):1606-14. PubMed ID: 10197636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryosurgery of tumor tissue causes endotoxin tolerance through an inflammatory response.
    Joosten JJ; van Muijen GN; Wobbes T; Ruers TJ
    Anticancer Res; 2003; 23(1A):427-32. PubMed ID: 12680243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer.
    Le Pivert PJ; Morrison DR; Haddad RS; Renard M; Aller A; Titus K; Doulat J
    Technol Cancer Res Treat; 2009 Jun; 8(3):207-16. PubMed ID: 19445538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage radical prostatectomy after failed transperineal cryotherapy: histologic findings from prostate whole-mount specimens correlated with intraoperative transrectal ultrasound images.
    Grampsas SA; Miller GJ; Crawford ED
    Urology; 1995 Jun; 45(6):936-41. PubMed ID: 7771026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.